Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $219.08 | 15 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $157.77 | 12 | $0 (2022) |
| ABBVIE INC. | $43.51 | 2 | $0 (2022) |
| BOSTON SCIENTIFIC CORPORATION | $17.80 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $58.93 | 3 | ABBVIE INC. ($43.51) |
| 2021 | $160.15 | 12 | Allergan, Inc. ($142.35) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2022 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $28.32 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/10/2022 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: GLAUCOMA | ||||||
| 02/11/2022 | Allergan, Inc. | VUITY (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/10/2021 | Allergan, Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $10.73 | General |
| Category: GLAUCOMA | ||||||
| 09/22/2021 | Allergan, Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: GLAUCOMA | ||||||
| 09/09/2021 | BOSTON SCIENTIFIC CORPORATION | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: STRUCTURAL HEART | ||||||
| 08/10/2021 | Allergan, Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: GLAUCOMA | ||||||
| 08/10/2021 | Allergan, Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $2.13 | General |
| Category: GLAUCOMA | ||||||
| 06/15/2021 | Allergan, Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $10.28 | General |
| Category: GLAUCOMA | ||||||
| 06/15/2021 | Allergan, Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $4.40 | General |
| Category: GLAUCOMA | ||||||
| 06/10/2021 | Allergan, Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: GLAUCOMA | ||||||
| 05/26/2021 | Allergan, Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $7.85 | General |
| Category: GLAUCOMA | ||||||
| 03/17/2021 | Allergan, Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: GLAUCOMA | ||||||
| 01/20/2021 | Allergan, Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: GLAUCOMA | ||||||
| 01/15/2021 | Allergan, Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $24.31 | General |
| Category: GLAUCOMA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 899 | 1,042 | $209,740 | $49,081 |
| 2022 | 14 | 1,323 | 4,837 | $375,479 | $89,899 |
| 2021 | 12 | 1,187 | 4,527 | $273,120 | $79,857 |
| 2020 | 9 | 758 | 1,058 | $188,400 | $59,518 |
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 239 | 252 | $69,300 | $17,408 | 25.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 167 | 268 | $46,900 | $13,322 | 28.4% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 62 | 62 | $21,700 | $4,486 | 20.7% |
| 92133 | Imaging of optic nerve | Office | 2023 | 157 | 161 | $15,295 | $3,257 | 21.3% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 12 | 14 | $21,000 | $3,020 | 14.4% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 79 | 79 | $11,850 | $2,444 | 20.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 21 | 29 | $6,525 | $1,959 | 30.0% |
| 92134 | Imaging of retina | Office | 2023 | 58 | 73 | $6,935 | $1,671 | 24.1% |
| 92250 | Photography of the retina | Office | 2023 | 47 | 47 | $6,815 | $769.55 | 11.3% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 31 | 31 | $1,860 | $566.95 | 30.5% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 26 | 26 | $1,560 | $177.66 | 11.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 202 | 458 | $79,475 | $25,709 | 32.3% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 255 | 298 | $81,760 | $20,731 | 25.4% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 120 | 120 | $41,755 | $10,220 | 24.5% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2022 | 33 | 42 | $61,430 | $9,269 | 15.1% |
| 92133 | Imaging of optic nerve | Office | 2022 | 216 | 218 | $20,710 | $4,604 | 22.2% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 113 | 122 | $18,200 | $4,380 | 24.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 33 | 51 | $11,455 | $4,085 | 35.7% |
| 92134 | Imaging of retina | Office | 2022 | 88 | 128 | $12,160 | $3,157 | 26.0% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Office | 2022 | 25 | 3,151 | $21,600 | $2,559 | 11.8% |
| 92250 | Photography of the retina | Office | 2022 | 97 | 106 | $15,370 | $2,402 | 15.6% |
| 92020 | Exam of the internal drainage system of eye | Office | 2022 | 54 | 56 | $3,348 | $981.45 | 29.3% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 20 | 20 | $3,700 | $953.03 | 25.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 20 | 20 | $1,776 | $515.04 | 29.0% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2022 | 47 | 47 | $2,740 | $333.73 | 12.2% |
About Dr. Allan Bogdan, MD
Dr. Allan Bogdan, MD is a Ophthalmology healthcare provider based in Rockport, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/24/2007. The National Provider Identifier (NPI) number assigned to this provider is 1205036472.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Allan Bogdan, MD has received a total of $219.08 in payments from pharmaceutical and medical device companies, with $58.93 received in 2022. These payments were reported across 15 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($219.08).
As a Medicare-enrolled provider, Bogdan has provided services to 4,167 Medicare beneficiaries, totaling 11,464 services with total Medicare billing of $278,355. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Location Rockport, ME
- Active Since 07/24/2007
- Last Updated 01/10/2019
- Taxonomy Code 207W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1205036472
Products in Payments
- DURYSTA (Drug) $157.54
- LUMIGAN (Drug) $28.32
- WATCHMAN (Device) $17.80
- VUITY (Drug) $15.42
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.